Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association of COVID-19 Infection and Relapse of Idiopathic Membranous Nephropathy

NCT05691179 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT05691179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05691179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association of COVID-19 Infection and Relapse of Idiopathic Membranous Nephropathy
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 10, 2022
Completion date
May 31, 2023
Enrollment
130 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic membranous nephropathy